Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Genmab a::S symbols : Glaxf save search
Targeted Therapy Global Market Report 2023: Increasing Prevalence of Cancer Drives Growth
Published: 2023-05-15 (Crawled : 17:00) - prnewswire.com
GNMSF | $285.11 3.83% 420
|
Health Technology
|
| O: 0.24%
H: 0.66%
C: 0.66%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
TAK | $13.15 -0.61% 0.0% 1.6M
|
Health Technology
|
| O: 0.61%
H: 0.3%
C: 0.24%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: 0.2%
H: 0.13%
C: -0.22%
GSK | $39.6 -0.88% 0.0% 2.8M
|
Health Technology
|
| O: 0.27%
H: 0.6%
C: 0.41%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: 0.0%
GMAB | $28.51 -3.13% -3.23% 360K
|
Health Technology
|
| O: 0.38%
H: 0.91%
C: 0.69%
AMGN | $264.07 -0.59% -0.59% 2.2M
|
Health Technology
|
| O: 0.14%
H: 0.28%
C: 0.11%
report cancer global therapy growth market
Cancer Monoclonal Antibodies Market Report 2022: Rising Preference for Personalized Medicines Provides Boost to Sector
Published: 2022-11-04 (Crawled : 18:00) - prnewswire.com
GNMSF | $285.11 3.83% 420
|
Health Technology
|
| O: -2.57%
H: 3.43%
C: 2.04%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.28%
H: 0.0%
C: 0.0%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: 1.13%
H: 0.63%
C: 0.53%
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: 0.0%
GSK | $39.6 -0.88% 0.0% 2.8M
|
Health Technology
|
| O: 1.25%
H: 0.03%
C: -0.78%
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 0.97%
H: 0.18%
C: -2.13%
BMY | $47.84 -0.87% -0.02% 12M
|
Health Technology
|
| O: 0.42%
H: 0.59%
C: -0.04%
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: 0.64%
H: 0.16%
C: -0.05%
GMAB | $28.51 -3.13% -3.23% 360K
|
Health Technology
|
| O: 0.58%
H: 0.93%
C: 0.93%
AMGN | $264.07 -0.59% -0.59% 2.2M
|
Health Technology
|
| O: -1.48%
H: 2.81%
C: 2.71%
report cancer market
Worldwide T-cell Lymphoma Industry to 2028 - Featuring Genmab, Seagen and GlaxoSmithKline Among Others
Published: 2022-04-28 (Crawled : 21:00) - prnewswire.com
GNMSF | $285.11 3.83% 420
|
Health Technology
|
| O: 2.93%
H: 1.47%
C: 1.33%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.05%
H: 0.0%
C: -0.99%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: 0.19%
H: 0.59%
C: -1.36%
GSK | $39.6 -0.88% 0.0% 2.8M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
BMY | $47.84 -0.87% -0.02% 12M
|
Health Technology
|
| O: -3.61%
H: 3.02%
C: 2.02%
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
|
| O: -1.67%
H: 0.0%
C: 0.0%
GMAB | $28.51 -3.13% -3.23% 360K
|
Health Technology
|
| O: 1.4%
H: 0.82%
C: -1.07%
t-cell
Hematological Malignancies Drugs Market worth $ 42.78 Billion by 2030 - Exclusive Report by InsightAce Analytic
Published: 2022-03-08 (Crawled : 11:00) - prnewswire.com
GNMSF | $285.11 3.83% 420
|
Health Technology
|
| O: -0.14%
H: 5.36%
C: 5.36%
TAK | $13.15 -0.61% 0.0% 1.6M
|
Health Technology
|
| O: -2.75%
H: 0.28%
C: -1.04%
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
GSK | $39.6 -0.88% 0.0% 2.8M
|
Health Technology
|
| O: 0.38%
H: 1.81%
C: 0.28%
BMY | $47.84 -0.87% -0.02% 12M
|
Health Technology
|
| O: -1.55%
H: 0.71%
C: -0.28%
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: 0.29%
H: 0.6%
C: -1.24%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
GILD | $66.94 -0.55% -0.55% 5.3M
|
Health Technology
|
| O: 1.4%
H: 0.7%
C: -1.15%
GMAB | $28.51 -3.13% -3.23% 360K
|
Health Technology
|
| O: -0.3%
H: 3.38%
C: 0.32%
AMGN | $264.07 -0.59% -0.59% 2.2M
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: 0.0%
ema drug report
Worldwide Drug Delivery Industry to 2027 - Growing Focus Towards Home Care and Self-Administration Presents Opportunities
Published: 2022-02-23 (Crawled : 18:00) - prnewswire.com
GNMSF | $285.11 3.83% 420
|
Health Technology
|
| O: 5.23%
H: 0.0%
C: -0.34%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.48%
H: 3.79%
C: 3.12%
AZNCF | $135.305 -4.19% 1.1K
|
Health Technology
|
| O: 1.68%
H: 0.0%
C: -1.1%
WST | $377.36 -0.56% 0.0% 360K
|
Health Technology
|
| O: 0.24%
H: 0.24%
C: -3.38%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: 1.82%
H: 0.07%
C: -1.0%
MDT | News | $79.08 -0.22% 0.0% 5.5M
|
Health Technology
|
| O: 0.5%
H: 0.25%
C: -1.16%
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: 0.23%
H: 0.7%
C: -0.18%
GSK | $39.6 -0.88% 0.0% 2.8M
|
Health Technology
|
| O: 1.9%
H: 0.07%
C: -0.87%
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 0.59%
H: 0.89%
C: -0.93%
BDX | $232.21 0.52% -0.52% 1.5M
|
Health Technology
|
| O: 0.22%
H: 1.9%
C: 1.48%
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: 0.45%
H: 1.46%
C: 0.37%
MMM | $90.96 -0.1% 0.0% 3.4M
|
Producer Manufacturing
|
| O: 0.0%
H: 0.4%
C: -1.61%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 2.09%
H: 0.08%
C: -1.22%
GMAB | $28.51 -3.13% -3.23% 360K
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: -1.67%
AZN | $68.53 0.39% 0.39% 3.7M
|
Health Technology
|
| O: 1.43%
H: 0.0%
C: -1.85%
ATRS | $5.59 0.0%
|
Health Technology
|
| O: 0.29%
H: 0.87%
C: -2.6%
AMGN | $264.07 -0.59% -0.59% 2.2M
|
Health Technology
|
| O: 0.57%
H: 0.48%
C: -0.75%
drug liver growing drug delivery
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.